January 23, 2025 – The Hebrew University of Jerusalem proudly congratulates three of its esteemed researchers for receiving the prestigious European Research Council (ERC) Proof of Concept grants. These follow-up grants, each valued at €150,000 (approximately $163,215 USD), support researchers in advancing their groundbreaking work into practical applications. This recognition continues a proud tradition of excellence at the Hebrew University, with numerous scholars having earned ERC grants in previous years.

The recipients from Hebrew University are:

Prof. Elad Gross, Head of the Surface Chemistry Laboratory and Chair of the Department of Chemistry, for his development of an innovative anti-corrosion coating for iron and steel. Corrosion of iron and steel poses a major technological challenge, weakening materials and reducing their functionality. Prof. Gross’s lab has developed a groundbreaking molecular coating that prevents rust formation. This ultra-thin, environmentally friendly, dual-layer coating has demonstrated exceptional efficacy in laboratory tests. The project aims to refine this technology, address technical barriers, and create a cost-efficient solution that could significantly extend the lifespan of iron and steel in industries such as transportation, aerospace, shipping, energy, and infrastructure.

Prof. Ami Citri, from the Edmond and Lily Safra Center for Brain Sciences (ELSC), for his work on improving the safety and efficacy of psychiatric medications. Prof. Citri’s project involves developing a novel automated system, HOMECAGE, for the continuous and precise monitoring of individual biological models within a social group. By maintaining their social structure, this innovative system supports preclinical trials for evaluating psychiatric medication safety and efficacy. HOMECAGE is expected to enhance experimental precision, reduce costs, and facilitate the development of safer and more effective treatments for neurological and psychiatric disorders.

Prof. Danny Ben-Zvi, from the Faculty of Medicine, for his work on preserving muscle and bone mass during weight loss. Rapid weight loss, whether through surgery, medication, or lifestyle changes, often leads to a loss of not only fat tissue but also muscle and bone mass. This can result in increased risks of conditions such as sarcopenia and osteoporosis. With the growing availability of weight-loss medications, preserving muscle and bone mass is becoming increasingly critical. Prof. Ben-Zvi’s project focuses on developing new molecules to prevent muscle and bone loss during weight reduction by enhancing the body’s natural mechanisms for maintaining strength.